Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Adams

Showing results (521-530 of 602) with videos related to

Pageof 61
Sort By:
Nature|March 15, 2018
Placentation defects are highly prevalent in embryonic lethal mouse mutantsVicente Perez-Garcia, Elena Fineberg, Robert Wilson, et al.
Nature Communications|June 28, 2019
Common and distinct transcriptional signatures of mammalian embryonic lethalityJohn E Collins, Richard J White, Nicole Staudt, et al.
Blood|October 3, 2018
A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleedingConstance C F M J Baaten, Stuart Meacham, Susanne M de Witt, et al.
The British Journal of Dermatology|November 15, 2024
Exploring the genetic driver events of eccrine poromas and porocarcinomas: a retrospective, cross-institutional study of 54 casesMark J Arends, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.
Nature Neuroscience|January 10, 2018
Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humansThomas Gstrein, Andrew Edwards, Anna Přistoupilová, et al.
Nature Communications|May 17, 2022
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
The British Journal of Dermatology|November 7, 2024
Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategyLouise van der Weyden, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.
Blood|January 20, 2022
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemiaCavan Bennett, Moyra Lawrence, Jose A Guerrero, et al.
Plos Genetics|December 17, 2009
Discovery of candidate disease genes in ENU-induced mouse mutants by large-scale sequencing, including a splice-site mutation in nucleoredoxinMelissa K Boles, Bonney M Wilkinson, Laurens G Wilming, et al.
Nature Communications|February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Pageof 61

Showing results (521-530 of 602) with videos related to

Sort By:
Pageof 61
Nature|March 15, 2018
Placentation defects are highly prevalent in embryonic lethal mouse mutantsVicente Perez-Garcia, Elena Fineberg, Robert Wilson, et al.
Nature Communications|June 28, 2019
Common and distinct transcriptional signatures of mammalian embryonic lethalityJohn E Collins, Richard J White, Nicole Staudt, et al.
Blood|October 3, 2018
A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleedingConstance C F M J Baaten, Stuart Meacham, Susanne M de Witt, et al.
The British Journal of Dermatology|November 15, 2024
Exploring the genetic driver events of eccrine poromas and porocarcinomas: a retrospective, cross-institutional study of 54 casesMark J Arends, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.
Nature Neuroscience|January 10, 2018
Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humansThomas Gstrein, Andrew Edwards, Anna Přistoupilová, et al.
Nature Communications|May 17, 2022
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
The British Journal of Dermatology|November 7, 2024
Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategyLouise van der Weyden, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.
Blood|January 20, 2022
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemiaCavan Bennett, Moyra Lawrence, Jose A Guerrero, et al.
Plos Genetics|December 17, 2009
Discovery of candidate disease genes in ENU-induced mouse mutants by large-scale sequencing, including a splice-site mutation in nucleoredoxinMelissa K Boles, Bonney M Wilkinson, Laurens G Wilming, et al.
Nature Communications|February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Pageof 61